First results from the International Breast Cancer Intervention Study (IBIS-I): a randomised prevention trial

Beatson, 1896, On the treatment of inoperable cases of carcinoma of the mamma: suggestions for a new method of treatment with illustrative cases, Lancet, 2, 104, 10.1016/S0140-6736(01)72307-0 Lacassagne, 1936, Hormonal pathogenesis of adenocarcinoma of the breast, Am J Cancer, 14, 217, 10.1158/ajc.1936.217 Pike, 1983, Hormonal risk factors, breast tissue age and the age-incidence of breast cancer, Nature, 303, 767, 10.1038/303767a0 Thomas, 1997, A prospective study of endogenous serum hormone concentrations and breast cancer risk in post-menopausal women on the island of Guernsey, Br J Cancer, 76, 401, 10.1038/bjc.1997.398 Cuzick, 1985, Tamoxifen and contralateral breast cancer, Lancet, 1, 282, 10.1016/S0140-6736(85)90338-1 Cuzick, 1986, The prevention of breast cancer, Lancet, 2, 83, 10.1016/S0140-6736(86)90729-4 Early Breast Cancer Trialists' Collaborative Group, 1998, Tamoxifen for early breast cancer: an overviw of the randomised trials, Lancet, 351, 1451, 10.1016/S0140-6736(97)11423-4 Powles, 1990, Prevention of breast cancer with tamoxifen: an update on the Royal Marsden Hospital pilot programme, Eur J Cancer, 26, 680, 10.1016/0277-5379(90)90116-B Powles, 1998, Interim analysis of the incidence of breast cancer in the Royal Marsden Hospital tamoxifen randomised chemoprevention trial, Lancer, 352, 98, 10.1016/S0140-6736(98)85012-5 Fisher, 1998, Tamoxifen for prevention of breast cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study, J Natl Cancer Inst, 90, 1371, 10.1093/jnci/90.18.1371 Veronesi, 1998, Prevention of breast cancer with tamoxifen: preliminary findings from the Italian randomised trial among hysterectomised women, Lancet, 352, 93, 10.1016/S0140-6736(98)85011-3 Cuzick, 1996, Chemoprevention of breast cancer with tamoxifen, 95 Cuzick, 2000, A brief review of the current breast cancer prevention trials and proposals for future trials, Eur J Cancer, 36, 1298, 10.1016/S0959-8049(00)00106-4 Cauley, 2001, Continued breast cancer risk reduction in postmenopausal women treated with raloxifene: 4-year results from the MORE trial, Breast Cancer Res Treat, 65, 125, 10.1023/A:1006478317173 National Health Service, 2001 Grady, 2000, Postmenopausal hormone therapy increases risk for venous thromboembolic disease: the Heart and Estrogen/progestin Replacement Study, Ann Intern Med, 132, 689, 10.7326/0003-4819-132-9-200005020-00002 Mosca, 2001, Hormone replacement therapy and cardiovascular disease: a statement for healthcare professionals from the American Heart Association, Circulation, 104, 499, 10.1161/hc2901.092200 The ATAC (Arimidex, Tamoxifen Alone or in Combination) Trialists' Group, 2002, Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trial, Lancet, 359, 2131, 10.1016/S0140-6736(02)09088-8